HOME >> MEDICINE >> NEWS
National Tropical Botanical Garden reports possible dietary link and neurodegenerative disease

Kalaheo, HI November 10, 2003 A study published in today's online Proceedings of the National Academy of Sciences suggests a possible dietary link to a devastating neurological disease that has long afflicted the Chamorro population of Guam. Drs. Paul Alan Cox, Sandra Banack, and Susan J. Murch of the National Tropical Botanical Garden's Institute for Ethnobotany in Hawaii found that a neurotoxin (BMAA) produced by cyanobacteria, which lives in the roots of the Guamanian cycad tree, accumulates in the food chain of the Chamorros a process known as biomagnification. This was confirmed when the researchers discovered BMAA in the brain tissue of Chamorros who died from the disease, amyotrophic lateral sclerosis-Parkinsonism dementia complex (ALS-PDC).

"Drs. Banack, Murch and I found BMAA in increasingly higher concentrations as it moved up the food chain to the Chamarros up to 1,000 times higher in their food source than in the cyanobacteria," said Dr. Cox, Director of the Institute for Ethnobotany. "Our study shows there is a link between cyanobacterial BMAA and Guamanian ALS-PDC."

People with ALS-PDC may exhibit symptoms of amyotrophic lateral sclerosis (ALS; also known as Lou Gehrig's disease), Alzheimer's, and Parkinson's disease. ALS-PDC is virtually limited to the Chamorro people of Guam, and at one time, occurred at 50 to100 times the rate of ALS elsewhere.

Previous research1 by Dr. Cox and the neurologist Oliver Sacks, M.D., suggests that the Chamorros were exposed to BMAA through consumption of a type of bat, flying foxes, which feed on cycad seeds. They also theorized that biomagnification occurred, in which neurotoxins accumulate in successively higher levels from cycad seeds to flying foxes to the Chamorro people.

Dr. Cox likens the biomagnification of BMAA, an amino acid once found only in cycads, to the biomagnification of mercury, DDT, PCBs, and other pesticides and pollutants that accumulate to often dangerous le
'"/>

Contact: Todd Ringler
todd.ringler@edelman.com
212-704-4572
Edelman Public Relations
10-Nov-2003


Page: 1 2

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. National Academies News: William H. Foege to receive Public Welfare Medal, Academys highest honor
3. National Academies news: Academy honors 17 for major contributions to science
4. National Academies advisory: Report assesses health implications of perchlorate exposure
5. National Academies Advisory: Jan. 11 public briefing on perchlorate in drinking water
6. National Academies news: Gulf War and Health
7. National survey shows few physicians elected to Congress
8. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
9. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
10. National Academies advisory: Nov. 4-6 Frontiers of Science meeting in Irvine, Calif.
11. National Chemistry Week celebrates health and wellness in Washington, D.C., area

Post Your Comments:
(Date:4/23/2014)... Cancer Center researchers say clinical trials for a ... (AML) are very promising. Patients treated with CPX-351, ... daunorubicin, are showing better responses than patients treated ... , "Acute myeloid leukemia is an aggressive blood ... especially in older patients," explained Jeffrey Lancet, M.D., ...
(Date:4/23/2014)... The American Society for Radiation Oncology (ASTRO) has ... Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based ... therapy in the treatment of endometrial cancer. The ... 2014 issue of Practical Radiation Oncology ... The full-length guideline is available as an open-access ...
(Date:4/23/2014)... that targets an important brain receptor has a dramatic ... relapse behavior, a University at Buffalo animal study has ... may be a novel lead compound for treating cocaine ... research was published as an online preview article in ... the compound, RO5263397, severely blunted a broad range of ...
(Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
(Date:4/23/2014)... Ill. - In a country as wealthy as the United ... 12 seniors do not have access to adequate food due ... food insecure. , Recent research at the University of ... Survey (NHANES) revealed that the seniors who are dealing with ... , "In 2011, 8.35 percent of Americans over age 60 ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
Cached News: